We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.32B
AUM Growth
+$18.4M
Cap. Flow
+$63.1M
Cap. Flow %
4.78%
Top 10 Hldgs %
33.66%
Holding
527
New
34
Increased
323
Reduced
125
Closed
25

Top Buys

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$29.1M
2
GLD icon
SPDR Gold Trust
GLD
+$19.8M
3
WMT icon
Walmart Inc
WMT
+$17M
4
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$13.8M
5
AMAT icon
Applied Materials
AMAT
+$4.96M

Top Sells

Rank Stock Value
1
UGL icon
ProShares Ultra Gold
UGL
+$12.5M
2
AZN icon
AstraZeneca
AZN
+$8.14M
3
AVGO icon
Broadcom
AVGO
+$5.93M
4
MSFT icon
Microsoft
MSFT
+$4.33M
5
APH icon
Amphenol
APH
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 35.21%
2 Healthcare 22.82%
3 Communication Services 11.05%
4 Consumer Discretionary 8.42%
5 Consumer Staples 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALVO icon
351
Alvotech
ALVO
$1.36B
$201K 0.02%
58,612
+7,606
+15% +$33.4K
OMER icon
352
Omeros
OMER
$992M
$200K 0.02%
18,982
+2,429
+15% +$28.6K
SVRA icon
353
Savara
SVRA
$1.17B
$197K 0.01%
36,107
+2,952
+9% +$16.4K
TECX
354
Tectonic Therapeutic
TECX
$720M
$196K 0.01%
6,332
+282
+5% +$6.94K
GHRS icon
355
GH Research
GHRS
$2.08B
$190K 0.01%
13,507
+3,400
+34% +$52.2K
IRTC icon
356
iRhythm Holdings
IRTC
$4.13B
$189K 0.01%
1,600
+1,400
+700% +$202K
ABCL icon
357
AbCellera Biologics
ABCL
$3.18B
$188K 0.01%
53,798
+5,021
+10% +$18.1K
COLL icon
358
Collegium Pharmaceutical
COLL
$834M
$186K 0.01%
5,635
+484
+9% +$20.5K
QURE icon
359
uniQure
QURE
$3.13B
$181K 0.01%
11,054
+904
+9% +$18.3K
KALV
360
DELISTED
KalVista Pharmaceuticals
KALV
$181K 0.01%
8,970
+734
+9% +$11.8K
CTNM
361
Contineum Therapeutics
CTNM
$564M
$176K 0.01%
13,503
+9,739
+259% +$131K
GRFS
362
Grifois
GRFS
$5.4B
$174K 0.01%
21,649
+1,770
+9% +$15.6K
INBX icon
363
Inhibrx
INBX
$1.44B
$174K 0.01%
2,581
+211
+9% +$15.7K
AVBP icon
364
ArriVent BioPharma
AVBP
$1.47B
$169K 0.01%
7,326
+599
+9% +$13.5K
GERN icon
365
Geron
GERN
$1.01B
$169K 0.01%
113,281
+9,261
+9% +$14.1K
KPTI icon
366
Karyopharm Therapeutics
KPTI
$46M
$167K 0.01%
+30,000
New +$229K
PCRX icon
367
Pacira BioSciences
PCRX
$945M
$162K 0.01%
7,185
+175
+2% +$3.89K
ARVN icon
368
Arvinas
ARVN
$580M
$158K 0.01%
14,950
+4,485
+43% +$55.5K
AMPH icon
369
Amphastar Pharmaceuticals
AMPH
$850M
$158K 0.01%
8,051
+563
+8% +$13.8K
XNCR icon
370
Xencor
XNCR
$1.72B
$157K 0.01%
13,015
+1,379
+12% +$17.1K
FTRE icon
371
Fortrea Holdings
FTRE
$1.74B
$156K 0.01%
16,592
+1,535
+10% +$19.7K
PHAT icon
372
Phathom Pharmaceuticals
PHAT
$742M
$155K 0.01%
13,983
+2,391
+21% +$30.2K
ABUS icon
373
Arbutus Biopharma
ABUS
$907M
$154K 0.01%
34,129
+2,790
+9% +$12.2K
JANX icon
374
Janux Therapeutics
JANX
$1.02B
$150K 0.01%
10,795
+994
+10% +$13.6K
URGN icon
375
UroGen Pharma
URGN
$2.39B
$149K 0.01%
8,307
+680
+9% +$13.6K
13 14
15
16 17

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q1 2026 Portfolio in Review

As of Q1 2026, China Universal Asset Management Company held 527 positions worth $1.32B, up 1.4% from $1.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

China Universal Asset Management Company deployed $63.1M of net new capital in Q1 2026, opening 34 new positions and adding to 323 existing holdings. Its largest new stake was TJX Companies: 13,200 shares worth $2.11M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 38% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was ProShares Ultra Gold, an estimated $12.5M trimmed.

  • China Universal Asset Management Company's largest Q1 2026 buy was TJX Companies: 13,200 shares worth $2.11M.
  • China Universal Asset Management Company added most to iShares Gold Trust in Q1 2026, an estimated $29.1M increase.
  • China Universal Asset Management Company's biggest Q1 2026 reduction was ProShares Ultra Gold, cutting an estimated $12.5M.
  • China Universal Asset Management Company fully exited ServiceNow in Q1 2026, selling an estimated $2.5M.
  • China Universal Asset Management Company's ten largest holdings make up 34% of its $1.32B portfolio in Q1 2026.
  • China Universal Asset Management Company opened 34 new positions and closed 25 in Q1 2026.
  • China Universal Asset Management Company's portfolio value rose 1.4% quarter-over-quarter to $1.32B.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.